LifeStance Health Group (NASDAQ:LFST) Given New $15.00 Price Target at JPMorgan Chase & Co.

LifeStance Health Group (NASDAQ:LFST) had its price objective increased by analysts at JPMorgan Chase & Co. from $13.00 to $15.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 3.72% from the company’s current price.

A number of other equities analysts have also commented on the company. BTIG Research lifted their price objective on LifeStance Health Group from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Wall Street Zen lowered LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th. Canaccord Genuity Group lifted their price target on LifeStance Health Group from $15.00 to $16.00 and gave the stock a “buy” rating in a research report on Friday, November 6th. Weiss Ratings reiterated a “hold (c)” rating on shares of LifeStance Health Group in a report on Wednesday, November 4th. Finally, Barclays increased their price objective on LifeStance Health Group from $13.00 to $15.00 and gave the company an “overweight” rating in a research report on Thursday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $14.00.

LifeStance Health Group Stock Performance

NASDAQ:LFST opened at $14.46 on Thursday. The firm has a market capitalization of $5.50 billion, a PE ratio of 76.12 and a beta of 1.35. LifeStance Health Group has a 1 year low of $6.01 and a 1 year high of $15.66. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.17. The firm’s fifty day simple moving average is $12.74 and its 200 day simple moving average is $9.60.

LifeStance Health Group (NASDAQ:LFST) last released its earnings results on Thursday, November 5th. The company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. LifeStance Health Group had a net margin of 4.29% and a return on equity of 4.82%. The firm had revenue of $455.86 million during the quarter, compared to analyst estimates of $431.59 million. The company’s quarterly revenue was up 25.3% on a year-over-year basis. On average, sell-side analysts anticipate that LifeStance Health Group will post 0.18 EPS for the current year.

Insiders Place Their Bets

In related news, CTO Vukasin Paunovich sold 42,067 shares of LifeStance Health Group stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $12.87, for a total transaction of $541,402.29. Following the sale, the chief technology officer directly owned 205,379 shares of the company’s stock, valued at $2,643,227.73. This trade represents a 17.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On LifeStance Health Group

Several large investors have recently added to or reduced their stakes in the company. Advisors Asset Management Inc. bought a new stake in shares of LifeStance Health Group during the third quarter valued at approximately $64,000. Landscape Capital Management L.L.C. bought a new position in LifeStance Health Group in the third quarter worth $335,000. Voya Investment Management LLC lifted its position in LifeStance Health Group by 1,249.6% in the third quarter. Voya Investment Management LLC now owns 3,971,989 shares of the company’s stock worth $47,783,000 after purchasing an additional 3,677,679 shares during the period. Public Sector Pension Investment Board boosted its stake in LifeStance Health Group by 16.6% during the third quarter. Public Sector Pension Investment Board now owns 917,743 shares of the company’s stock worth $11,311,000 after buying an additional 130,640 shares in the last quarter. Finally, Global Retirement Partners LLC boosted its stake in LifeStance Health Group by 4.6% during the third quarter. Global Retirement Partners LLC now owns 55,928 shares of the company’s stock worth $673,000 after buying an additional 2,480 shares in the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals. Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance’s clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders. Founded in 2017, LifeStance has expanded its network across the United States.